PT100668B - Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos - Google Patents
Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos Download PDFInfo
- Publication number
- PT100668B PT100668B PT100668A PT10066892A PT100668B PT 100668 B PT100668 B PT 100668B PT 100668 A PT100668 A PT 100668A PT 10066892 A PT10066892 A PT 10066892A PT 100668 B PT100668 B PT 100668B
- Authority
- PT
- Portugal
- Prior art keywords
- corydalis
- extract
- extracts
- pharmaceutical composition
- eschsoltzia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
- A61K36/505—Corydalis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4122706A DE4122706C1 (cg-RX-API-DMAC7.html) | 1991-07-09 | 1991-07-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT100668A PT100668A (pt) | 1993-09-30 |
| PT100668B true PT100668B (pt) | 1999-08-31 |
Family
ID=6435763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT100668A PT100668B (pt) | 1991-07-09 | 1992-07-08 | Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos |
Country Status (26)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5460819A (en) * | 1991-12-13 | 1995-10-24 | Children's Medical Center Corporation | Method for treating PQQ-responsive heavy metal toxicity |
| FR2743721B1 (fr) * | 1996-01-19 | 1998-04-03 | Innothera Lab Sa | Association mineralo-phytotherapique sous forme galenique unitaire de comprimes |
| DE69943415D1 (de) * | 1998-03-26 | 2011-06-16 | Phytopharm Plc Godmanchester | Sarsasapogenin und Smilagenin zur Behandlung kognitiver Störungen |
| BR0010379A (pt) | 1999-03-11 | 2001-12-26 | Dan Verser | Processo para a produção de etanol |
| US7074603B2 (en) * | 1999-03-11 | 2006-07-11 | Zeachem, Inc. | Process for producing ethanol from corn dry milling |
| US6521634B2 (en) | 2001-03-28 | 2003-02-18 | The Hong Kong University Of Science & Technology | Uses of dl-THP |
| KR20030063735A (ko) * | 2002-01-23 | 2003-07-31 | 주식회사 석산터메디칼 | 신경성 질환 예방 및 치료를 위한 약제학적 조성물 및,실험용 동물에 신경성 질환을 일으키는 방법 |
| US7341745B2 (en) * | 2003-02-07 | 2008-03-11 | Arizona Health Consulting, Llc | Method for decreasing nicotine and other substance use in humans |
| NZ586246A (en) * | 2004-01-29 | 2013-03-28 | Zeachem Inc | Recovery of organic acids from a fermentation broth |
| FR2878163B1 (fr) * | 2004-11-25 | 2007-04-27 | R & D Pharma | Nouvelles compositions pharmaceutiques a visee phytotherapeutique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR961M (cg-RX-API-DMAC7.html) * | 1961-03-03 | 1961-11-27 | ||
| DE1467868A1 (de) * | 1964-10-20 | 1969-01-30 | Dainippon Pharmaceutical Co | Verfahren zur Herstellung eines gegen Geschwuere des Verdauungstraktes wirksamen Medikamentes |
| JPS60181023A (ja) * | 1984-02-28 | 1985-09-14 | Nitto Electric Ind Co Ltd | 漢方局所麻酔性組成物 |
-
1991
- 1991-07-09 DE DE4122706A patent/DE4122706C1/de not_active Expired - Fee Related
-
1992
- 1992-07-02 AU AU19370/92A patent/AU652262B2/en not_active Ceased
- 1992-07-02 CA CA002072950A patent/CA2072950A1/en not_active Abandoned
- 1992-07-03 IL IL102410A patent/IL102410A/en not_active IP Right Cessation
- 1992-07-06 YU YU67492A patent/YU48554B/sh unknown
- 1992-07-07 ZA ZA925059A patent/ZA925059B/xx unknown
- 1992-07-07 US US07/909,675 patent/US5308619A/en not_active Expired - Fee Related
- 1992-07-08 KR KR1019920012112A patent/KR100225010B1/ko not_active Expired - Fee Related
- 1992-07-08 PT PT100668A patent/PT100668B/pt not_active IP Right Cessation
- 1992-07-08 SI SI19929200138A patent/SI9200138A/sl unknown
- 1992-07-08 RU SU925052267A patent/RU2072859C1/ru active
- 1992-07-08 EG EG37092A patent/EG20140A/xx active
- 1992-07-08 MX MX9204011A patent/MX9204011A/es not_active IP Right Cessation
- 1992-07-08 IE IE922226A patent/IE74691B1/en not_active IP Right Cessation
- 1992-07-09 EP EP92111709A patent/EP0535317B1/de not_active Expired - Lifetime
- 1992-07-09 AT AT92111709T patent/ATE139446T1/de not_active IP Right Cessation
- 1992-07-09 SK SK2143-92A patent/SK279531B6/sk unknown
- 1992-07-09 JP JP4182626A patent/JPH085796B2/ja not_active Expired - Lifetime
- 1992-07-09 ES ES92111709T patent/ES2088053T3/es not_active Expired - Lifetime
- 1992-07-09 DE DE59206608T patent/DE59206608D1/de not_active Expired - Fee Related
- 1992-07-09 DK DK92111709.9T patent/DK0535317T3/da active
- 1992-07-09 CZ CS922143A patent/CZ279915B6/cs not_active IP Right Cessation
- 1992-07-09 HU HU9202274A patent/HUT61668A/hu unknown
-
1993
- 1993-03-12 UA UA93002403A patent/UA26971C2/uk unknown
-
1994
- 1994-08-09 EE EE9400046A patent/EE03169B1/xx unknown
- 1994-12-30 MD MD95-0171A patent/MD1139G2/ro unknown
-
1996
- 1996-06-20 GR GR960401185T patent/GR3020289T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Prange et al. | L-tryptophan in mania: Contribution to a permissive hypothesis of affective disorders | |
| EP1377278B1 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv | |
| PT100668B (pt) | Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos | |
| CN107441104B (zh) | 人参二醇皂苷Rb组分防治糖尿病并发症及代谢紊乱相关疾病的医药用途 | |
| Sung et al. | Prolonged increase in blood pressure by a single oral dose of caffeine in mildly hypertensive men | |
| Medon et al. | Influence of quipazine, a potential anti-parkinsonian agent on the uptake of 3H-dopamine and 3H-serotonin into rat striatal tissue in vitro | |
| US20020058712A1 (en) | Treatment of fibromyalgia with ubiquinone 10 and succinic acid | |
| FI117374B (fi) | Hyperglykemian vastaisesti vaikuttavat lääkeaineet | |
| Hashim Fauzy et al. | Piper sarmentosum leaves aqueous extract attenuates vascular endothelial dysfunction in spontaneously hypertensive rats | |
| Wirz-Justice et al. | Increased platelet serotonin in bipolar depression and hypomania | |
| Duraisami et al. | Evaluation of antidiabetic efficacy of polyherbal formulations in experimentally induced hyperglycemic rats | |
| Abrahamsson et al. | Effect of Short-Term Treatment with Pivalic Acid Containing Antibiotics on Serum Carnitine Concentration-A Risk Irrespective of Age | |
| Surapongchai et al. | Angiotensin II induces differential insulin action in rat skeletal muscle | |
| KR0168748B1 (ko) | 혈당 강하용 인삼 음료와 소프트 캡슐 | |
| RU2146529C1 (ru) | Набор антиалкогольных средств | |
| Hedner et al. | Stimulation of minor salivary glands by intraoral treatment with the cholinesterase inhibitor physostigmine in man | |
| EP1150669A1 (en) | L-arginine based formulations for treating diseases and methods of using same | |
| LT3355B (en) | Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions | |
| JP2008074796A (ja) | 抗糖尿病食品 | |
| US5180739A (en) | Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent type of autoimmune diseases | |
| KR100523446B1 (ko) | 유향으로부터 얻은 5' 에이엠피-활성화 단백질 인산화효소 활성용 추출물 | |
| KR20060034879A (ko) | 항당뇨 효과를 나타내는 발효구아바 조성물 | |
| Ask | Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum | |
| Yoshikawa | Xylitol infusion related to pathophysiology in anesthesia | |
| WO2015092043A1 (fr) | Combinaison de bézafibrate et de resvératrol ou de dérivés de resvératrol pour le traitement et la prévention des maladies impliquant un dysfonctionnement énergétique des mitochondries |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19930507 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19990511 |
|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20011130 |